Operating Segments (Tables)

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Schedule of operating segments

	Three Months Ended June 30,
	2019			2018
Revenues
Public Health Solutions	$	1,095,865		$	1,449,044
Specialized BioTherapeutics		449,099			276,501
Total	$	1,544,964		$	1,725,545
Income (Loss) from Operations
Public Health Solutions	$	204,121		$	30,299
Specialized BioTherapeutics		(1,463,334	)		(923,960	)
Corporate		(905,678	)		(695,629	)
Total	$	(2,164,891	)	$	(1,589,290	)
Amortization and Depreciation Expense
Public Health Solutions	$	4,316		$	4,512
Specialized BioTherapeutics		4,168			5,345
Corporate		4,448			1,313
Total	$	12,932		$	11,170
Interest Income, Net
Corporate	$	39,851		$	32,948
Share-Based Compensation
Public Health Solutions	$	8,072		$	12,818
Specialized BioTherapeutics		19,094			21,898
Corporate		45,726			55,709
Total	$	72,892		$	90,425

	Six months Ended June 30,
	2019			2018
Revenues
Public Health Solutions	$	1,776,218		$	2,258,300
Specialized BioTherapeutics		913,534			587,018
Total	$	2,689,752		$	2,845,318
Income/(Loss) from Operations
Public Health Solutions	$	195,110		$	(55,906	)
Specialized BioTherapeutics		(2,798,891	)		(2,445,308	)
Corporate		(1,861,173	)		(1,482,177	)
Total	$	(4,464,954	)	$	(3,983,391	)
Amortization and Depreciation Expense
Public Health Solutions	$	8,718		$	8,992
Specialized BioTherapeutics		8,845			10,729
Corporate		5,429			2,663
Total	$	22,992		$	22,384
Interest Income, Net
Corporate	$	84,604		$	49,843
Share-Based Compensation
Public Health Solutions	$	13,268		$	28,486
Specialized BioTherapeutics		40,002			50,216
Corporate		99,195			119,693
Total	$	152,465		$	198,395

	As of June 30, 2019		As of December 31, 2018
Identifiable Assets
Public Health Solutions	$	1,564,020	$	1,181,114
Specialized BioTherapeutics		150,782		78,336
Corporate		7,478,161		9,232,252
Total	$	9,192,963	$	10,491,702